Tag: warning letters

Lessons From High-Profile GMP Enforcement Cases and Consent Decrees Key Lessons From High-Profile GMP Enforcement Cases and Consent Decrees Pharmaceutical manufacturers frequently face GMP inspections and audits globally, driven by regulatory bodies such as the US FDA, EMA, MHRA, PIC/S, and WHO. These regulatory inspections are critical for ensuring manufacturing compliance with Good Manufacturing Practice…

Read More “Lessons From High-Profile GMP Enforcement Cases and Consent Decrees” »

How to Survive a For-Cause Inspection After a Product Complaint Step-by-Step Guide to Survive a For-Cause GMP Inspection After a Product Complaint For pharmaceutical manufacturers operating under the stringent quality and regulatory standards established by the FDA, EMA, MHRA, PIC/S, and WHO, a for-cause GMP inspection subsequent to a product complaint represents one of the…

Read More “How to Survive a For-Cause Inspection After a Product Complaint” »

Preventing Surprise GMP Findings in Critical Utilities and HVAC Step-by-Step Guide to Preventing Surprise GMP Findings in Critical Utilities and HVAC In pharmaceutical manufacturing, critical utilities and HVAC systems are foundational to maintaining product quality and compliance with Good Manufacturing Practice (GMP). Regulatory agencies such as the US FDA, EMA, MHRA, and PIC/S place high…

Read More “Preventing Surprise GMP Findings in Critical Utilities and HVAC” »

Using Visual Management Boards to Demonstrate GMP Control Implementing Visual Management Boards to Enhance GMP Control in Pharmaceutical Manufacturing The pharmaceutical industry operates under rigorous regulatory scrutiny, with adherence to current Good Manufacturing Practice (GMP) regulations being essential for patient safety and product quality. For US, UK, and EU manufacturers, demonstrating effective control during GMP…

Read More “Using Visual Management Boards to Demonstrate GMP Control” »

Responding to Regulator Concerns on Data Integrity During Inspections Step-by-Step Guide to Responding to Regulator Concerns on Data Integrity During GMP Inspections Data integrity remains a cornerstone of pharmaceutical Good Manufacturing Practice (GMP) compliance and a critical focus area during GMP inspection and GMP audit activities. Maintaining robust data integrity practices is essential not only…

Read More “Responding to Regulator Concerns on Data Integrity During Inspections” »

Explaining Complex IT and Automation Setups to Non-Technical Inspectors How to Effectively Explain Complex IT and Automation Systems During GMP Inspections Pharmaceutical manufacturing environments increasingly rely on sophisticated IT and automation systems to ensure product quality, process control, and data integrity. However, during GMP inspections such as FDA 483 observations, GMP audits, or regulatory inspections…

Read More “Explaining Complex IT and Automation Setups to Non-Technical Inspectors” »

Managing Multi-Language Batch Records During Inspections Effective Management of Multi-Language Batch Records During GMP Inspections Pharmaceutical manufacturers operating across global markets increasingly face the challenge of managing multi-language batch records during regulatory oversight such as FDA 483 observations, GMP inspections, and GMP audits. Ensuring these complex documents meet regulatory expectations is critical to maintaining inspection…

Read More “Managing Multi-Language Batch Records During Inspections” »

Preparing a Site for Its First Ever FDA or MHRA GMP Inspection Step-by-Step Guide to Preparing a Site for Its First Ever FDA or MHRA GMP Inspection For pharmaceutical manufacturers in the US, UK, and EU, the anticipation of the first Good Manufacturing Practice (GMP) inspection by regulatory authorities such as the FDA or the…

Read More “Preparing a Site for Its First Ever FDA or MHRA GMP Inspection” »

GMP Inspection Planning for Newly Commissioned Facilities Step-by-Step Guide: GMP Inspection Planning for Newly Commissioned Facilities Entering the pharmaceutical manufacturing arena with a newly commissioned facility presents significant opportunities and challenges alike. Compliance with Good Manufacturing Practice (GMP) regulations and expectations is paramount to ensuring product quality, patient safety, and regulatory approval. Effective GMP inspection…

Read More “GMP Inspection Planning for Newly Commissioned Facilities” »

Preparing a Risk-Based List of “High-Interest” Areas for Inspectors: Step-by-Step GMP Tutorial Step-by-Step Guide to Preparing a Risk-Based List of “High-Interest” Areas for Inspectors For pharmaceutical manufacturers, regulatory bodies such as the FDA, EMA, MHRA, and PIC/S emphasize the importance of inspection readiness to ensure compliance with Good Manufacturing Practice (GMP) standards. One of the…

Read More “Preparing a Risk-Based List of “High-Interest” Areas for Inspectors” »